Clinical Trial Update: WithDRawal Impact Of Postoperative Beta-Blocker [NA]

View source ↗

Summary

A terminated clinical trial evaluated the impact of withdrawing postoperative beta-blocker therapy in patients undergoing coronary artery bypass grafting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Beta-blocker

Snippet

Sponsor: Yale University | Conditions: Coronary Artery Bypass | NA | Status: TERMINATED